KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Payables (2016 - 2026)

Zimmer Biomet Holdings has reported Payables over the past 18 years, most recently at $361.2 million for Q1 2026.

  • For Q1 2026, Payables rose 19.88% year-over-year to $361.2 million; the TTM value through Mar 2026 reached $361.2 million, up 19.88%, while the annual FY2025 figure was $303.0 million, 55.7% up from the prior year.
  • Payables for Q1 2026 was $361.2 million at Zimmer Biomet Holdings, up from $303.0 million in the prior quarter.
  • Over five years, Payables peaked at $437.1 million in Q4 2022 and troughed at $194.6 million in Q4 2024.
  • A 5-year average of $337.7 million and a median of $333.9 million in 2022 define the central range for Payables.
  • Biggest five-year swings in Payables: tumbled 52.61% in 2024 and later soared 55.7% in 2025.
  • Year by year, Payables stood at $437.1 million in 2022, then fell by 6.06% to $410.6 million in 2023, then tumbled by 52.61% to $194.6 million in 2024, then surged by 55.7% to $303.0 million in 2025, then grew by 19.21% to $361.2 million in 2026.
  • Business Quant data shows Payables for ZBH at $361.2 million in Q1 2026, $303.0 million in Q4 2025, and $315.3 million in Q3 2025.